Wells Fargo & Company Sema4 Holdings Corp. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.24 - $0.52 $13,095 - $28,374	54,566 Added 419.74%	67,566 $22,000
Q4 2022 Feb 13, 2023	SELL	$0.22 - $1.04 $802 - $3,793	-3,648 Reduced 21.91%	13,000 $3,000
Q3 2022 Nov 14, 2022	BUY	$0.25 - $2.4 $3,208 - $30,801	12,834 Added 336.5%	16,648 $14,000
Q2 2022 Aug 12, 2022	BUY	$1.22 - $3.05 $2,265 - $5,663	1,857 Added 94.89%	3,814 $4,000
Q1 2022 May 16, 2022	SELL	$2.64 - $4.67 $266 - $471	-101 Reduced 4.91%	1,957 $6,000
Q4 2021 Feb 14, 2022	SELL	$4.4 - $8.8 $7,216 - $14,432	-1,640 Reduced 44.35%	2,058 $9,000
Q3 2021 Nov 15, 2021	BUY	$7.44 - $13.99 $27,513 - $51,735	3,698 New	3,698 $28,000

166K

Ticker SMFR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 380,641,984
Market Cap $129M
Description
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.